These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24993931)

  • 41. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
    Fatemi HM; Doody K; Griesinger G; Witjes H; Mannaerts B
    Hum Reprod; 2013 Feb; 28(2):442-52. PubMed ID: 23136144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follicular-phase endometrial scratching: a truncated randomized controlled trial.
    Mackens S; Racca A; Van de Velde H; Drakopoulos P; Tournaye H; Stoop D; Blockeel C; Santos-Ribeiro S
    Hum Reprod; 2020 May; 35(5):1090-1098. PubMed ID: 32372078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction technology.
    Peeraer K; Debrock S; Laenen A; De Loecker P; Spiessens C; De Neubourg D; D'Hooghe TM
    Hum Reprod; 2014 Feb; 29(2):267-75. PubMed ID: 24282120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlled ovarian hyperstimulation leads to high progesterone and estradiol levels during early pregnancy.
    Järvelä IY; Pelkonen S; Uimari O; Mäkikallio K; Puukka K; Ruokonen A; Tekay A; Martikainen H
    Hum Reprod; 2014 Nov; 29(11):2393-401. PubMed ID: 25205752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP; Blockeel C; Verpoest W; De Vos M; Stoop D; Vloeberghs V; Camus M; Devroey P; Tournaye H
    Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frozen-thawed embryo transfer in a natural or mildly hormonally stimulated cycle in women with regular ovulatory cycles: a RCT.
    Peeraer K; Couck I; Debrock S; De Neubourg D; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Meuleman C; D'Hooghe T
    Hum Reprod; 2015 Nov; 30(11):2552-62. PubMed ID: 26364081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paracervical block as pain treatment during second-trimester medical termination of pregnancy: an RCT with bupivacaine versus sodium chloride.
    Andersson IM; Benson L; Christensson K; Gemzell-Danielsson K
    Hum Reprod; 2016 Jan; 31(1):67-74. PubMed ID: 26573530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration.
    Santos-Ribeiro S; Polyzos NP; Haentjens P; Smitz J; Camus M; Tournaye H; Blockeel C
    Hum Reprod; 2014 Aug; 29(8):1698-705. PubMed ID: 24939956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.
    Giorgetti C; Vanden Meerschaut F; De Roo C; Saunier O; Quarello E; Hairion D; Penaranda G; Chabert-Orsini V; De Sutter P
    Hum Reprod; 2013 Oct; 28(10):2636-42. PubMed ID: 23887070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of follicle flushing during oocyte retrieval in assisted reproductive technologies: a systematic review and meta-analysis.
    Levy G; Hill MJ; Ramirez CI; Correa L; Ryan ME; DeCherney AH; Levens ED; Whitcomb BW
    Hum Reprod; 2012 Aug; 27(8):2373-9. PubMed ID: 22647450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Catastrophic payment for assisted reproduction techniques with conventional ovarian stimulation in the public health sector of South Africa: frequency and coping strategies.
    Dyer SJ; Sherwood K; McIntyre D; Ataguba JE
    Hum Reprod; 2013 Oct; 28(10):2755-64. PubMed ID: 23878180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. e-Therapy to reduce emotional distress in women undergoing assisted reproductive technology (ART): a feasibility randomized controlled trial.
    van Dongen AJ; Nelen WL; IntHout J; Kremer JA; Verhaak CM
    Hum Reprod; 2016 May; 31(5):1046-57. PubMed ID: 26965429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment.
    Thalluri V; Tremellen KP
    Hum Reprod; 2012 Dec; 27(12):3487-92. PubMed ID: 22997247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The history of Belgian assisted reproduction technology cycle registration and control: a case study in reducing the incidence of multiple pregnancy.
    De Neubourg D; Bogaerts K; Wyns C; Albert A; Camus M; Candeur M; Degueldre M; Delbaere A; Delvigne A; De Sutter P; Dhont M; Dubois M; Englert Y; Gillain N; Gordts S; Hautecoeur W; Lesaffre E; Lejeune B; Leroy F; Ombelet W; Perrier D'Hauterive S; Vandekerckhove F; Van der Elst J; D'Hooghe T
    Hum Reprod; 2013 Oct; 28(10):2709-19. PubMed ID: 23820420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.
    Polyzos NP; De Vos M; Corona R; Vloeberghs V; Ortega-Hrepich C; Stoop D; Tournaye H
    Hum Reprod; 2013 May; 28(5):1254-60. PubMed ID: 23442756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Sirt3 in mitochondrial biogenesis and developmental competence of human in vitro matured oocytes.
    Zhao HC; Ding T; Ren Y; Li TJ; Li R; Fan Y; Yan J; Zhao Y; Li M; Yu Y; Qiao J
    Hum Reprod; 2016 Mar; 31(3):607-22. PubMed ID: 26787646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation between follicle dimensions recorded by patients at home (SOET) versus ultrasound performed by professional care providers.
    Dalewyn L; Deschepper E; Gerris J
    Facts Views Vis Obgyn; 2017 Sep; 9(3):153-156. PubMed ID: 29479400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.